AEON Biopharma raises $6M private placement, plans Daewoong note exchange for ~23M shares

AEON Biopharma, Inc.

First closing of private placement expected week of Nov 17, 2025: 1,964,905 shares/pre-funded warrants at $0.9116 per share.
Second closing subject to stockholder approval: 4,616,924 shares and 6,581,829 warrants at $1.09392.
Term sheet with Daewoong to exchange existing notes for $1.5M new note, ~23.1M shares, and 8M warrants.
True-Up Warrants issued to maintain investor ownership percentage post-Daewoong exchange.
Investors receive registration rights for resale of shares and warrant shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.